Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — August 2022

Genmab — August 2022

Planlagt Fastgjort Låst Flyttet Genmab
1.1k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • S Offline
    S Offline
    Stroka
    wrote on sidst redigeret af
    #948

    God formiddag. 🙂

    1 Reply Last reply
    0
    • BulderB Offline
      BulderB Offline
      Bulder
      wrote on sidst redigeret af
      #949

      Tak bibob. Lovende fremtid for tec-dara-kombien. 74% orr i rrmm for pts som tidligere har fået anti cd38 er stærkt.

      1 Reply Last reply
      0
      • BulderB Offline
        BulderB Offline
        Bulder
        wrote on sidst redigeret af
        #950

        Og så er den steroid-fri. Det er der mange der bliver glade for.

        1 Reply Last reply
        0
        • J Offline
          J Offline
          JKY_VH
          wrote on sidst redigeret af
          #951

          Tak bibob:-)

          1 Reply Last reply
          0
          • BulderB Offline
            BulderB Offline
            Bulder
            wrote on sidst redigeret af
            #952

            Blenrep har stærke data og er godkendt i både eu og us i 5. Linje. Men der er dette her øjen-problem…

            1 Reply Last reply
            0
            • BulderB Offline
              BulderB Offline
              Bulder
              wrote on sidst redigeret af
              #953

              Link Preview Image
              See Boxed Warning | Side Effects | BLENREP (belantamab mafodotin-blmf)

              Review side effects for BLENREP (belantamab mafodotin-blmf), which is only available through the REMS program. See PI including Boxed Warning and Medication Guide for patients. For US residents only.

              favicon

              (www.blenrep.com)

              1 Reply Last reply
              0
              • B Offline
                B Offline
                bibob
                wrote on sidst redigeret af
                #954

                TRIMM - 3 https://clinicaltrials.gov/ct2/show/NCT05338775?term=Trimm+2&draw=2&rank=2

                1 Reply Last reply
                0
                • B Offline
                  B Offline
                  bibob
                  wrote on sidst redigeret af
                  #955

                  Troede kun der var et TRIMM -2. ??

                  1 Reply Last reply
                  0
                  • S Offline
                    S Offline
                    Sukkeralf
                    wrote on sidst redigeret af
                    #956

                    Spændende at man igen forsøge sig med checkpoint inhibitorer i MM

                    1 Reply Last reply
                    0
                    • D Offline
                      D Offline
                      deleted-user
                      wrote on sidst redigeret af
                      #957

                      God eftermiddag. Selvom Genmab og JNJ ligger og slås en smule i den dumme voldgift, så fornemmer man, at samarbejdet de kommende mange år vil definere MM markedet med Dara, Tec, Tal og måske super-dara i spil

                      1 Reply Last reply
                      0
                      • BulderB Offline
                        BulderB Offline
                        Bulder
                        wrote on sidst redigeret af
                        #958

                        Mon PD-1 inhibitoren er Cetrelimab? https://www.jnj.com/janssen-presents-results-from-phase-1b-2-norse-study-in-patients-with-metastatic-or-locally-advanced-urothelial-carcinoma-treated-with-balversa-erdafitinib-in-combination-with-cetrelimab-a-pd-1-inhibitor

                        1 Reply Last reply
                        0
                        • Helge_LarsenPI-redaktørH Offline
                          Helge_LarsenPI-redaktørH Offline
                          Helge_LarsenPI-redaktør
                          wrote on sidst redigeret af
                          #959

                          Lidt flere spørgsmål til Q&A er mere end velkommen. 🙂

                          1 Reply Last reply
                          0
                          • B Offline
                            B Offline
                            bibob
                            wrote on sidst redigeret af
                            #960

                            Bulder 14.17. Det ville nok være nærliggende at tro. Da det er et in House drug.

                            1 Reply Last reply
                            0
                            • Helge_LarsenPI-redaktørH Offline
                              Helge_LarsenPI-redaktørH Offline
                              Helge_LarsenPI-redaktør
                              wrote on sidst redigeret af
                              #961

                              Godmorgen. 🙂

                              1 Reply Last reply
                              0
                              • P Offline
                                P Offline
                                ProinvestorNEWS
                                wrote on sidst redigeret af
                                #962

                                Godmorgen. 🙂

                                1 Reply Last reply
                                0
                                • P Offline
                                  P Offline
                                  ProinvestorNEWS
                                  wrote on sidst redigeret af
                                  #963

                                  Asian Markets Tumble Amid Global Sell-off https://www.proinvestor.com/investornyt/872173/asian-markets-tumble-amid-global-sell-off

                                  1 Reply Last reply
                                  0
                                  • S Offline
                                    S Offline
                                    Stroka
                                    wrote on sidst redigeret af
                                    #964

                                    God morgen. 🙂

                                    1 Reply Last reply
                                    0
                                    • P Offline
                                      P Offline
                                      ProinvestorNEWS
                                      wrote on sidst redigeret af
                                      #965

                                      Asien: Udsigt til strammere pengepolitik i USA og EU sender aktier ned https://www.proinvestor.com/investornyt/872177/asien-udsigt-til-strammere-pengepolitik-i-usa-og-eu-sender-aktier-ned

                                      1 Reply Last reply
                                      0
                                      • P Offline
                                        P Offline
                                        ProinvestorNEWS
                                        wrote on sidst redigeret af
                                        #966

                                        Aktier efter Jackson Hole: Intet nyt var skidt nyt https://www.proinvestor.com/boards/105698

                                        1 Reply Last reply
                                        0
                                        • P Offline
                                          P Offline
                                          ProinvestorNEWS
                                          wrote on sidst redigeret af
                                          #967

                                          Aktier/åbning: Rød dyne over C25 efter Powell-tale
                                          https://www.proinvestor.com/investornyt/872209/aktier-abning-rod-dyne-over-c25-efter-powell-tale

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper